Preventative Effect of Montelukast in Mild To Moderate Contrast-Induced Acute Kidney Injury in Rats Via Nadph Oxidase 4, P22phox and Nuclear Factor Kappa-B Expressions

Loading...
Publication Logo

Date

2025-02-21

Journal Title

Journal ISSN

Volume Title

Publisher

Springer

Open Access Color

Green Open Access

No

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Top 10%

Research Projects

Journal Issue

Abstract

Reactive oxygen species (ROS) generation, inflammation and apoptosis are observed in contrast-induced acute kidney injury (CI-AKI). NOX4, isoform of NADPH oxidase main regulatory enzyme for ROS generation, is mostly expressed in the kidney and co-localized with p22phox. It is investigated the effect of antioxidant, anti-inflammatory and anti-apoptotic montelukast pre-treatment on expression of NOX4, p22phox and NF-kappa B in preventing CI-AKI in rats in this study. Wistar male rats randomized into four groups: 1. Control (C), 2. CI-AKI (iohexol; 3 g iodine/kg), 3. Montelukast (10 mg/kg) (M), 4. M + CI-AKI. Rats sacrificed on the 7th day. Urine and serum creatinine and serum Kidney injury molecule-1 (KIM-1) levels measured. NF-kappa B, NOX-4, p22phox mRNA and protein expressions, TNF-alpha, KIM-1 mRNA expressions, ROS and caspase-3 evaluated from kidney tissue. Histological injury scored. ANOVA and Kruskal-Wallis tests were used for analysis parametric and nonparametric data, respectively. p < 0.05 considered statistically significant. Tubular injury score, KIM-1 and caspase-3 levels increased in CI-AKI group compared to C group (p < 0.05). TNF-alpha, NF-kappa B, NOX-4, p22phox, KIM-1 mRNA expressions and ROS levels increased in CI-AKI group compared to C group (p < 0.001 and p < 0.05). NF-kappa B, NOX-4, p22phox protein expressions increased in CI-AKI group compared to C group (p < 0.05) and decreased in the M + CI-AKI group compared to CI-AKI group (p < 0.01, p < 0.05, p < 0.05). TNF-alpha, NF-kappa B, NOX-4, p22phox, KIM-1 mRNA expressions and ROS levels decreased with montelukast pre-treatment (p < 0.001). One of the mechanism of increased ROS level in the CI-AKI model is related the increase the expression of NOX4 and p22phox and montelukast pre-treatment has a protective effect by decreasing NOX4 and p22phox mRNA and protein expressions.

Description

Baris, Elif/0000-0001-6838-7932; Simsek, Oguzhan/0000-0003-2756-8440

Keywords

Contrast-Induced Nephropathy, Montelukast, Oxidative Stress, Nox4, P22Phox

Fields of Science

Citation

WoS Q

Q3

Scopus Q

Q2
OpenCitations Logo
OpenCitations Citation Count
N/A

Source

International Urology and Nephrology

Volume

57

Issue

7

Start Page

2313

End Page

2325
PlumX Metrics
Citations

CrossRef : 1

Scopus : 2

PubMed : 1

Captures

Mendeley Readers : 3

SCOPUS™ Citations

2

checked on May 01, 2026

Web of Science™ Citations

2

checked on May 01, 2026

Page Views

2

checked on May 01, 2026

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
6.2473

Sustainable Development Goals

SDG data is not available